The return of ‘base business’

The last few weeks (or is it months?) there's been lots of references to 'the base business.'  For some years in the early part of this decade, everyone - generics companies and their followers in the form of analysts and the media - was riveted by the western generics markets -the billions of dollars worth of … Continue reading The return of ‘base business’